top of page

Inclusion of clinical opinions in economic evaluations

fre. 14. okt.

|

Kreftforeningens vitensenter / Streaming

This CONNECT seminar is about "Inclusion of clinical opinions in economic evaluations: From theory to practice"

Registration is closed
See other events
Inclusion of clinical opinions in economic evaluations
Inclusion of clinical opinions in economic evaluations

Time & Location

14. okt. 2022, 11:30 – 13:45

Kreftforeningens vitensenter / Streaming, Kongens gate 6, 0153 Oslo, Norway

About the event

Welcome to the CONNECT Seminar:

Inclusion of clinical opinions in economic evaluations: From theory to practice

Host: CONNECT Working Group 3

Date: Friday, October 14th, 2022; 11:30h – 13:45h (CET)

Venue:  Kreftforeningens Vitensenter, with opportunity to join digitally.

Register for in-person attendance here: https://kurs.kreftforeningen.no/inkludering-av-kliniske-ekspertvurderinger-i-metodevurderinger-fra-teori-til-praksis-2022042 (Please note. Registration is only for in-person/on-site attendance.)

Streaming here: https://livestream.kreftforeningen.no

AGENDA

Part 1: Inclusion of clinical opinions in economic evaluations - From theory to practice

11:30 – 12:00 Arrival and coffee for on-site participants // Log-in for digital participation

12:00 – 12:05 Welcome and Introduction

Eline Aas, Førsteamanuensis, Department of Health Management and Health Economics, University of Oslo; CONNECT WG3 Lead

12:05 – 12:40 Case Methods for Expert Elicitation in Health Care Decision Making

Professor Laura Bojke, Team Leader for Economic Evaluation & Health Technology Assessment; Health Economics, Evaluation & Equality (HEEE) theme lead, Centre for Health Economics, University of York

12:40 – 13:00 Reducing uncertainty surrounding cost-effectiveness of precision cancer medicine by including expert opinions

Magnus Bangum, Former master’s student at the Department of Health Management and Health Economics, University of Oslo

Part 2: Panel discussion – Future use of systematic implementation of clinical opinions

(This part will be in Norwegian)

13:00 – 13:45 Panelsamtale: Fremtidig systematisk bruk av klinikere

Moderator: Petter Foss, International Value and Access Partner Solid Tumors, Europe, Novartis Oncology

Jan Frich, Viseadministrerende direktør og Fagdirektør, Helse Sør-Øst RHF

Eline Aas, Professor, Department og Health Management and Health Economics, University of Oslo; CONNECT WG3 Lead

Magnus Bangum, Former master’s student at the Department of Health Management and Health Economics, University of Oslo

Fredrik Schjesvold, Head of Oslo Myeloma Center at Oslo University Hospital

Halfdan Sørbye, Overlege, Professor, Kreftavdelingen, Haukeland Universitetssykehus

Bente Kristin Johansen fra Legeforeningen

Kristin Svanqvist, Head of Governmental Affairs and Communication, Merck Norway

Contact: Jutta Heix, Head of International Affairs Oslo Cancer Cluster / Project Lead CONNECT; jh@oslocancercluster.no

Share this event

bottom of page